LBCA invites you this first session of a four part series on liquid biopsy/CtDNA tests and relevance for ILC. In this first session, clinician/researchers Drs. Julia Foldi and Rebecca Shatsky discuss topics including: when these tests may be useful in ILC treatment, what can and can’t yet be concluded from the test results for ILC patients, and how some clinicians are using these tests in treatment of ILC patients to complement imaging and other tests. The Q&A portion will be facilitated by Research Advocate Janet Axelrod. (Stay tuned for Information on future sessions in 2026).

December 17th, 12:00 – 1:00pm EST

Presenter(s):

Julia Foldi, MD, PhD, Assistant Professor of Medicine, Malignant Hematology and Medical Oncology, University of Pittsburgh

Rebecca Shatsky, MD, Professor of Clinical Medicine, Breast Medical Oncology Team Leader,  at University of California, San Diego Moores Cancer Center and member of the LBCA Scientific Advisory Board.

Janice Axelrod, MD, LBCA Founding Advocate and Research and Communications Officer